Communication in both digital and physical form is critical across research and development. Why? For starters, biopharma companies that eliminate paper communications could exclude prospective patients who prefer more traditional correspondence or lack access to email. When clinical studies skew towards an older generation, such exclusions can be detrimental to trial efficacy. Working with a cloud-based manufacturer that offers strategic consultation and a platform for ordering print materials online can make for a streamlined, end-to-end process. In this webinar, the team at FedEx Office will discuss a suite of print and communication offerings designed to support and simplify the drug development process from inception through completion. Topics include:
Request Free! |